1 |
What is the main advantage of using nanomaterials in electrochemical sensors for medical diagnostics?
|
3. They enhance sensitivity and surface area for detection |
|
It's state in abstract that the use of technology improve sensitivity.
|
It's state in abstract that the use of technology improve sensitivity.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
2 |
Which of the following nanomaterials is frequently mentioned as enhancing sensor conductivity?
|
2. Gold nanoparticles |
|
gold nanoparticleshave excellent electrical properties and biocompatibility which facilitate electron transfer between electrode and target.
|
gold nanoparticleshave excellent electrical properties and biocompatibility which facilitate electron transfer between electrode and target.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
3 |
Why are carbon-based nanomaterials such as carbon nanotubes (CNTs) useful in electrochemical sensors?
|
3. They improve electron transfer and mechanical strength |
|
Due to thier properties an excellent electrical consuctivity, high surface area and exceptional biocompatibility, its enhance electron transfer rate and improve detection limit.
|
A.R. Jalalvand and M.M. Karami, Sensing and Bio-Sensing Research 47, 2025, page 10-12 number 4.3
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
4 |
What is one challenge in integrating nanotechnology with electrochemical sensors for medical use?
|
3. Issues in reproducibility and standardization |
|
in the passage there is a mention that the reproducibility of sensor performance can affected by nanometerial synthesis and to stabilize production in commercial scale is also a challemge
|
A.R. Jalalvand and M.M. Karami, Sensing and Bio-Sensing Research 47, 2025, page 10-12 number 4.3
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
5 |
Which technique is commonly used to enhance the signal in nanotechnology-based electrochemical sensors?
|
2. Enzyme labeling |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
6 |
Why is biocompatibility crucial in designing electrochemical sensors for medical diagnostics?
|
2. To prevent rejection or toxicity in biological systems |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
7 |
How do label-free electrochemical sensors differ from labeled ones?
|
2. They offer indirect detection only |
|
lable free detecting binding events but labeled signaled through electroactive lables
|
lable free detecting binding events but labeled signaled through electroactive lables
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
8 |
What is one promising application of nanotech-based electrochemical sensors?
|
2. Early detection of disease biomarkers |
|
it can detect early change from biomarkers
|
it can detect early change from biomarkers
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
9 |
Which of the following factors most directly affects the sensor's detection limit?
|
2. Nanomaterial surface-to-volume ratio |
|
more surface lead to more active site for analytic interaction
|
more surface lead to more active site for analytic interaction
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
10 |
What is one of the primary goals of using digital sensing technologies in cancer care?
|
3. Enable earlier and more personalized diagnosis |
|
its provide early detection and realtime measurment which allowed early diagnoses and more personal because it detect directly from patient signal sent.
|
its provide early detection and realtime measurment which allowed early diagnoses and more personal because it detect directly from patient signal sent.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
11 |
Which type of sensor is often used to monitor physical activity in cancer patients?
|
1. Optical sensors |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
12 |
Why are patient-reported outcomes important in digital cancer care systems?
|
3. They provide subjective data complementing sensor metrics |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
13 |
What is one major advantage of real-time digital sensing in cancer treatment?
|
3. Rapid detection of deterioration in patient condition |
|
A.R. Jalalvand and M.M. Karami, Sensing and Bio-Sensing Research 47, 2025, page 16 number 6.3.3
|
A.R. Jalalvand and M.M. Karami, Sensing and Bio-Sensing Research 47, 2025, page 16 number 6.3.3
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
14 |
Which of the following is a key barrier to implementing digital sensing in routine oncology practice?
|
3. Limited digital literacy among patients and providers |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
15 |
Which stakeholders are considered central to the adoption of digital cancer care platforms?
|
2. Patients and healthcare providers |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
16 |
Digital sensing systems collect which combination of data types for cancer care optimization?
|
5. Radiotherapy schedules and family income |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
17 |
How do digital sensors contribute to improving the quality of life in cancer patients?
|
3. By enabling symptom tracking and early intervention |
|
the sensor allowed early detection and real-time measurement which help with symptom tracking and early intervention
|
the sensor allowed early detection and real-time measurement which help with symptom tracking and early intervention
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
18 |
What does the article suggest about the future direction of digital sensing in cancer care?
|
3. It holds promise for widespread personalized care |
|
it state that the technology is still developing with some promise result.
|
A.R. Jalalvand and M.M. Karami, Sensing and Bio-Sensing Research 47, 2025, page 19-21 number 8
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
19 |
Based on the diagram, which of the following would most likely result in a false signal output in an electrochemical sensor for medical diagnostics?
|
2. Increasing the number of bioreceptors without sample optimization |
|
in diagram stae about only how bioreceptors send changes to the sensor to detect signal
|
in diagram stae about only how bioreceptors send changes to the sensor to detect signal
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
20 |
Based on the image, which of the following scenarios best demonstrates the advantage of using emerging digital platforms in cancer diagnostics?
|
3. A portable chip-based sensor detects protein biomarkers from a blood sample within minutes |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|